Observational study / 1994
Lymphocytes from medication-free Crohn's disease patients showed increased proliferation in response to baker's yeast compared to healthy controls.
This study tested whether baker's yeast (Saccharomyces cerevisiae) plays a role in Crohn's disease. Peripheral blood leukocytes from 12 patients and 15 healthy controls were incubated with baker's yeast, and proliferation was measured via tritiated thymidine uptake after 3 days. None of the healthy controls displayed lymphocyte proliferation to yeast. In contrast, all 9 Crohn's disease patients in remission on no medication showed a threefold increase in their lymphocyte proliferation rate, while lymphocytes from 3 patients receiving 1.5 g olsalazine maintenance therapy failed to respond.
Shows an association, not proof of cause and effect.
- Study type
- Case-control in vitro study
- Who was studied
- 12 patients with Crohn's disease and 15 healthy controls (including 3 bakers)
- What was measured
- Lymphocyte proliferation rate in response to baker's yeast
THE PAPER
Lymphocyte proliferation response to baker's yeast in Crohn's disease.
Young CA, Sonnenberg A, Burns EA. Digestion, 1994.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.